Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.
NCT07266220 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2025-12-05
Summary
This study is being done at Assiut University to look for early signs of hardening of the arteries (atherosclerosis) in people who have both diabetes and chronic kidney disease (CKD). Many patients with these conditions are at higher risk of heart disease and stroke, but the disease can develop quietly without symptoms.
We will use a safe, non-invasive test called carotid Doppler ultrasound, which uses sound waves to check the neck arteries (carotid arteries) for early changes. The goal is to see how often these early changes occur in patients with diabetes and CKD, and whether the findings relate to their kidney function, blood sugar control, and other health factors.
This research may help doctors detect vascular problems earlier and guide better prevention strategies for patients at risk.
Conditions
- Diabetes Mellitus, Type 2
- Chronic Kidney Disease
- Atherosclerosis
Sponsors & Collaborators
-
Abdallah Ali Mohammed
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2027-03-31
- Completion
- 2027-04-30
More Related Trials
-
Effect of Citrate Dialysate on Vascular Calcification
NCT04956120 ·Status: COMPLETED ·Phase: NA
-
Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes
NCT00948116 ·Status: RECRUITING
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
NCT01722513 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
NCT03391830 ·Status: COMPLETED ·Phase: NA
-
Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes
NCT02808351 ·Status: COMPLETED ·Phase: PHASE4
-
Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy
NCT02088502 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Contrast Induced Acute Kidney in Patients With Acute Stroke
NCT03132558 ·Status: UNKNOWN
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
NCT03266458 ·Status: UNKNOWN
-
Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
NCT01458158 ·Status: UNKNOWN
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.
NCT03867994 ·Status: COMPLETED ·Phase: PHASE2
-
Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention
NCT04806633 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio
NCT01400295 ·Status: COMPLETED
-
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
NCT02575092 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Endothelial Microparticles: A Novel Marker of Vascular Dysfunction
NCT02230202 ·Status: COMPLETED
-
Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy
NCT02516072 ·Status: COMPLETED ·Phase: NA
-
The Acetylcysteine for Contrast-Induced Nephropathy Trial
NCT00736866 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetyl Cystein and Contrast Nephropathy
NCT01820195 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
NCT00556465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
NCT01704482 ·Status: COMPLETED ·Phase: PHASE2
-
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial
NCT03759158 ·Status: COMPLETED ·Phase: NA